Patheon is planning to consolidate its Puerto Rico operations into its manufacturing site located in Manati, and close or sell its plant in Caguas. Wes Wheeler, president and
Merck KGaA (Merck) has initiated multi-national Phase III study of the investigational therapeutic cancer vaccine Stimuvax (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer
Transgenomic has launched Surveyor Scan K-RAS kit for broad detection of mutations predictive of response to recently developed therapies. The kit features its proprietary Surveyor Nuclease and Wave
India-based ACG Worldwide has announced that it is planing to establish three new facilities at Shirwal, Pune, Maharashtra, India. The venture is expected to cost INR 4000m. The
Amgen has presented data from a phase 3, head-to-head trial of Denosumab versus Zometa (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast
Zentiva, a Czech pharmaceutical company, will start manufacturing generic version of Pfizer’s Viagra. The production will begin in 2010. The company will engage manufacturing site at Slovak town
Gilead Sciences has reported that FDA’s Anti-Infective Drugs Advisory Committee has recommended aztreonam for inhalation solution to be approved for the treatment of infections due to Pseudomonas aeruginosa
YM BioSciences has presented the first results of a collaborative program between the company and the National Research Council of Canada’s Biotechnology Research Institute (NRC-BRI). Utilising YM’s IntelliMab
Delta Industrial will be featuring its new web converting system at ATX West 2010. Demonstration of the Delta Mod-Tech in Booth 4325 will include in-line rotary die-cutting and
Biomatrica has launched DNAgard, a room temperature-based liquid formulation for stabilisation and storage of tissues and cells. The new DNAgard product is solutions for room-temperature storage, archiving, stabilisation
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.